J Korean Med Sci.
2018 Nov;33(45):e286. 10.3346/jkms.2018.33.e286.
Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
- Affiliations
-
- 1Center for Liver Cancer, National Cancer Center, Goyang, Korea. jwpark@ncc.re.kr
- KMID: 2424310
- DOI: http://doi.org/10.3346/jkms.2018.33.e286
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Treatments Other than Sorafenib for Patients with Advanced Hepatocellular Carcinoma
- Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
- Liver resection after sorafenib therapy in advanced hepatocellular carcinoma: a case report
- Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis
- Complete Response of Single Nodular Large Hepatocellular Carcinoma with Pulmonary Metastasis by Sequential Transarterial Chemoembolization and Sorafenib: A Case Report
